Exclusive

Publication

Byline

Location

US Patent Issued to Trustees of Boston University on Aug. 18 for "Regulated synthetic gene activation systems" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,637, issued on Aug. 18, was assigned to Trustees of Boston University (Boston). "Regulated synthetic gene activation systems" was invented ... Read More


US Patent Issued to NINGBO INNOVATIVE MECHANISM BIOSCIENCE on Aug. 18 for "Protein heterodimer and use thereof" (Chinese Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,638, issued on Aug. 18, was assigned to NINGBO INNOVATIVE MECHANISM BIOSCIENCE LLC (Ningbo City, China). "Protein heterodimer and use there... Read More


US Patent Issued to Kite Pharma on Aug. 18 for "Methods of administering chimeric antigen receptor immunotherapy" (California Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,639, issued on Aug. 18, was assigned to Kite Pharma Inc. (Santa Monica, Calif.). "Methods of administering chimeric antigen receptor immuno... Read More


US Patent Issued to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK on Aug. 18 for "Biodegradable textile fibers with inherent color and properties" (New York, California, Rhode Island Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,640, issued on Aug. 18, was assigned to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York). "Biodegradable textile fibe... Read More


US Patent Issued to VOYAGER THERAPEUTICS on Aug. 18 for "Tau binding compounds" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,641, issued on Aug. 18, was assigned to VOYAGER THERAPEUTICS INC. (Lexington, Mass.). "Tau binding compounds" was invented by Todd Carter (... Read More


US Patent Issued to SANOFI BIOTECHNOLOGY, REGENERON PHARMACEUTICALS on Aug. 18 for "Methods for treating nasal polyposis by administering an IL-4R antagonist" (American, French Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,642, issued on Aug. 18, was assigned to SANOFI BIOTECHNOLOGY (Gentilly, France) and REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.). "Meth... Read More


US Patent Issued to Galderma Holding on Aug. 18 for "Treatments for prurigo nodularis" (French, Swiss Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,643, issued on Aug. 18, was assigned to Galderma Holding SA (Zug, Switzerland). "Treatments for prurigo nodularis" was invented by Valerie ... Read More


US Patent Issued to Yale University on Aug. 18 for "Targeting gene amplification in cancer using triplex formation as a therapeutic strategy" (Connecticut Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,645, issued on Aug. 18, was assigned to Yale University (New Haven, Conn.). "Targeting gene amplification in cancer using triplex formation... Read More


US Patent Issued to Ablynx, Sanofi on Aug. 18 for "Polypeptides comprising immunoglobulin single variable domains targeting Glypican-3 and T cell receptor" (Belgian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,646, issued on Aug. 18, was assigned to Ablynx NV (Zwijnaarde, Belgium) and Sanofi (Paris). "Polypeptides comprising immunoglobulin single ... Read More


US Patent Issued to SYSTIMMUNE on Aug. 18 for "Multi-specific antibodies and methods of using thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,709,647, issued on Aug. 18, was assigned to SYSTIMMUNE INC. (Redmond, Wash.). "Multi-specific antibodies and methods of using thereof" was inve... Read More